Close

Allergan's (AGN) JUVEDERM VOLLURE XC Gains U.S. FDA Approval for Correction of Severe Facial Wrinkles & Folds

Go back to Allergan's (AGN) JUVEDERM VOLLURE XC Gains U.S. FDA Approval for Correction of Severe Facial Wrinkles & Folds
Allergan Inc (NYSE: AGN) Delayed: 193.02 --0 (-0%)
Previous Close $193.02    52 Week High $322.68 
Open $15.33    52 Week Low $186.34 
Day High $193.02    P/E 45.96 
Day Low $193.02    EPS $4.20 
Volume 43,377